Cerenome, Inc. Reports Q1 2026 Financial Results

What Happened
Cerenome, Inc. announced and reported its financial results for the first quarter ended March 31, 2026 in an 8-K filed August 14, 2026. The company furnished a press release announcing those quarterly results and other recent corporate updates as Exhibit 99.1 to the filing. The report was signed by Marc H. Hedrick, M.D., President and Chief Executive Officer.

Key Details

• Filing date: August 14, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026 (Q1 2026).
• Press release: Furnished as Exhibit 99.1 and incorporated by reference (dated August 14, 2026).
• Authorized signature: /s/ Marc H. Hedrick, M.D., President & CEO.

Why It Matters
This 8-K notifies investors that Cerenome has reported its latest quarterly results and provided a company press release with details. Retail investors should review the Exhibit 99.1 press release (and any subsequent filings) for specific metrics—such as revenue, net income or loss, cash position, and any guidance—since the 8-K itself references those results but does not include detailed financial line items in the body of the filing. Monitoring these updates is material for evaluating near-term performance and management commentary from the CEO.